• Chemistry Analysis
  • Separation Center
  • Center of Natural Product
  • Impurity Isolation and Identification
  • Physicochemical Characterization & Others
  • Pharmaceutical Analysis
  • ASMS Screening
  • Biology
  • In vitro Biology
  • Enzymes/Biochemical Assays
  • Ion Channel
  • Cellular Assays
  • GPCR, Transporter and NHR
  • Radioactive Assays
  • Cancer Cell Panel & In Vitro Oncology Assays
  • In Vitro Assays for Diabetes and Other Metabolic Diseases
  • High Throughput Screening
  • High Content Platform
  • Protein Expression and Purification
  • In vivo Pharmacology & PK/PD
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Fibrosis: Lung, Liver, Kidney
  • Central Nervous System & Pain
  • Respiratory: Asthma & COPD
  • IBS/IBD Animal Models
  • Large Animal Disease Models
  • Infectious Disease
  • Antiviral Services
  • Virology Assays Supporting Human Clinical Trials
  • Antibacterial In Vitro Screening and Pharmacology Services
  • HBV Platform
  • Safety and Early Toxicity
  • In Vitro Safety Profiling for Medchem Support
  • In Vitro Tox Assays for Medchem Support
  • Early Stage Safety Assessment
  • Oncology & Immunology
  • CRISPR/Cas9 Gene Editing
  • In Vitro & In Vivo Library Screening
  • In Vivo CRISPR Animal Models and Services
  • Gene Therapy
  • Tumor Models
  • Cell Line-Derived Xenograft (CDX) Tumor Models
  • Patient-Derived Xenograft (PDX) Tumor Models
  • Syngeneic Tumor Models
  • Human Immune Checkpoint Gene KI Mouse Models
  • hPBMC/HSC Humanized Models
  • Immuno-oncology
  • Translational Oncology
  • Biomarker
  • Discovery Biomarker
  • Clinical Biomarker
  • Autoimmune and Inflammatory Animal Models
  • OncoWuXi Database
  • Structure Based Drug Discovery
  • Protein Production
  • X-ray Crystallography
  • CryoEM
  • Biophysical Assays and Screening
  • FBDD - Fragment Screening
  • Biopharmaceutical Assays
  • Crelux
  • HD Biosciences
  • About Us
  • About WuXi RSD
  • RSD Leadership
  • About WuXi AppTec
  • News & Events
  • News
  • Upcoming Events
  • Resource Library
  • Newsletters
  • Latest Sciences
  • Literature Download
  • Contact
  • CN

    Enabling Unbounded Possibilities

    Take Your Research to the Next Level

    Learn More

    Enabling Unbounded Possibilities

    Delivering Comprehensive End-to-End Discovery Solutions

    Learn More

    Enabling Unbounded Possibilities

    A Trusted Partner with a Reputation for Scientific Excellence

    Learn More
    WuXi AppTec Research Service Division

    Delivering our partners preclinical discoveries through world class capabilities,

    directed by teams with a reputation for collaboration and scientific excellence

    Learn More
    Latest Science
    Magic Power of QM
    With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.

    Magic Power of QM

    To Empower Organic Syntheses

    With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.

    Drugging the Undruggable
    “In the past, thousands of proteins were considered undruggable. This meant that previous efforts to develop a drug against them failed. Today, the combination of novel chemical modalities and advanced technical approaches has resulted in new clinical candidates for previously undruggable targets.”

    Drugging the Undruggable

    Leveraging the Right Screening Methods for Challenging Targets

    “In the past, thousands of proteins were considered undruggable. This meant that previous efforts to develop a drug against them failed. Today, the combination of novel chemical modalities and advanced technical approaches has resulted in new clinical candidates for previously undruggable targets.”

    Women in Science
    We spoke to four leaders of research and business operations at WuXi AppTec to discuss their views on Women in Science in the 21st century.

    Women in Science

    Breaking the glass ceiling

    We spoke to four leaders of research and business operations at WuXi AppTec to discuss their views on Women in Science in the 21st century.

    Interview
    A Conversation with Richard Lerner: : DELopen Promotes Worldwide Academic Research Using DNA-Encoded Libraries, Far More Than Just a Numbers Game.

    Interview

    Richard Lerner, M.D.

    A Conversation with Richard Lerner: : DELopen Promotes Worldwide Academic Research Using DNA-Encoded Libraries, Far More Than Just a Numbers Game.

    Scientific Platform
    Cutting-edge synthetic technology and expertise in special chemical matters have been centralized to form a variety of special chemistry platforms.

    Scientific Platform

    Special Chemistry Platform

    Cutting-edge synthetic technology and expertise in special chemical matters have been centralized to form a variety of special chemistry platforms.

    DNA Encoded Library
    Instant Access to Billion of Compounds at Affordable Price. WuXi’s end-to-end platform enables smooth transition from DEL hit to hit validation, leading to downstream medicinal chemistry activities.

    DNA Encoded Library

    Accelerator for DEL Technology

    Instant Access to Billion of Compounds at Affordable Price. WuXi’s end-to-end platform enables smooth transition from DEL hit to hit validation, leading to downstream medicinal chemistry activities.

    Upcoming Events

    Drug Discovery Innovation Program (DDIP) | San Francisco, CA

    Oct 22-23, 2019

    Medicinal Chemistry and Pharma R&D Informatics | London, UK

    Oct 28-29, 2019

    Proventa Medicinal Chemistry Strategy Mtg | San Francisco, CA

    Oct 29, 2019

    Texas Life Science Forum | Houston, TX

    Nov 6, 2019

    SITC 2019 | National Harbor, MD

    Nov 6-10, 2019

    AASLD | Boston MA

    Nov 8-12 , 2019

    Tides Europe | Amsterdam, Netherlands

    Nov 12-15, 2019

    Proventa Biology Strategy Mtg East | Boston

    Nov 13, 2019

    Proventa Medicinal Chemistry East | Boston, MA

    Nov 14, 2019